June 27, 2022. The Virginia Innovation Partnership Corporation (VIPC) has notified Chorda Pharma that it will receive a grant from the Commonwealth Commercialization Fund (CCF) for the Commercialization of a Non-Opioid Topical Analgesic. The $75,000 award will be used to help fund the testing, pilot manufacturing, and marketing of Capsadyn™, which offers relief for patients suffering from chronic pain. Download full release.
June 2, 2021. Chorda Pharma is partnering with Carilion Clinic to develop, test, and market non-opioid medications to treat chronic pain. Download full release.
May 4, 2021. Serial entrepreneur and innovator Victor Iannello, Sc.D., has joined Roanoke-based Chorda Pharma as its CEO. Download full release.